nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2C9—brain cancer	0.509	1	CbGaD
Azelastine—CYP2D6—Lomustine—brain cancer	0.0527	0.164	CbGbCtD
Azelastine—CYP1A2—Carmustine—brain cancer	0.0522	0.162	CbGbCtD
Azelastine—CYP2D6—Hydroxyurea—brain cancer	0.04	0.124	CbGbCtD
Azelastine—CYP3A4—Temozolomide—brain cancer	0.0394	0.122	CbGbCtD
Azelastine—CYP3A4—Lomustine—brain cancer	0.0335	0.104	CbGbCtD
Azelastine—CYP2E1—Etoposide—brain cancer	0.0267	0.0829	CbGbCtD
Azelastine—CYP3A5—Etoposide—brain cancer	0.0208	0.0644	CbGbCtD
Azelastine—CYP2C8—Etoposide—brain cancer	0.02	0.062	CbGbCtD
Azelastine—CYP1A2—Etoposide—brain cancer	0.0155	0.048	CbGbCtD
Azelastine—ABCB1—Etoposide—brain cancer	0.0135	0.0419	CbGbCtD
Azelastine—CYP3A4—Etoposide—brain cancer	0.0081	0.0251	CbGbCtD
Azelastine—HRH1—nose—brain cancer	0.00269	0.113	CbGeAlD
Azelastine—HRH3—hindbrain—brain cancer	0.0025	0.105	CbGeAlD
Azelastine—Atovaquone—CYP2C9—brain cancer	0.00231	0.871	CrCbGaD
Azelastine—Mucosal inflammation—Hydroxyurea—brain cancer	0.00168	0.0227	CcSEcCtD
Azelastine—HRH3—brainstem—brain cancer	0.00143	0.06	CbGeAlD
Azelastine—Amenorrhoea—Procarbazine—brain cancer	0.00137	0.0185	CcSEcCtD
Azelastine—HRH3—telencephalon—brain cancer	0.00127	0.0532	CbGeAlD
Azelastine—Parosmia—Temozolomide—brain cancer	0.00112	0.0151	CcSEcCtD
Azelastine—Amenorrhoea—Hydroxyurea—brain cancer	0.00106	0.0143	CcSEcCtD
Azelastine—Mucosal inflammation—Etoposide—brain cancer	0.00105	0.0142	CcSEcCtD
Azelastine—Influenza-like symptoms—Temozolomide—brain cancer	0.00102	0.0137	CcSEcCtD
Azelastine—Ulcer—Hydroxyurea—brain cancer	0.000984	0.0133	CcSEcCtD
Azelastine—Visual impairment—Lomustine—brain cancer	0.000916	0.0124	CcSEcCtD
Azelastine—Breast pain—Temozolomide—brain cancer	0.000833	0.0112	CcSEcCtD
Azelastine—Amenorrhoea—Temozolomide—brain cancer	0.000827	0.0112	CcSEcCtD
Azelastine—Thinking abnormal—Carmustine—brain cancer	0.000822	0.0111	CcSEcCtD
Azelastine—Viral infection—Temozolomide—brain cancer	0.000805	0.0109	CcSEcCtD
Azelastine—HRH3—head—brain cancer	0.00079	0.0331	CbGeAlD
Azelastine—Herpes simplex—Temozolomide—brain cancer	0.000789	0.0106	CcSEcCtD
Azelastine—Infection—Carboplatin—brain cancer	0.000767	0.0104	CcSEcCtD
Azelastine—HRH3—central nervous system—brain cancer	0.000721	0.0303	CbGeAlD
Azelastine—Influenza like illness—Temozolomide—brain cancer	0.000706	0.00953	CcSEcCtD
Azelastine—HRH3—cerebellum—brain cancer	0.000705	0.0296	CbGeAlD
Azelastine—Pollakiuria—Procarbazine—brain cancer	0.000697	0.0094	CcSEcCtD
Azelastine—Infection—Lomustine—brain cancer	0.000671	0.00906	CcSEcCtD
Azelastine—Pain—Carboplatin—brain cancer	0.00066	0.00891	CcSEcCtD
Azelastine—Abnormal vision—Carmustine—brain cancer	0.000656	0.00885	CcSEcCtD
Azelastine—Mental disability—Carmustine—brain cancer	0.000653	0.00881	CcSEcCtD
Azelastine—Face oedema—Hydroxyurea—brain cancer	0.000652	0.0088	CcSEcCtD
Azelastine—Haematuria—Procarbazine—brain cancer	0.000641	0.00865	CcSEcCtD
Azelastine—Epistaxis—Procarbazine—brain cancer	0.000634	0.00856	CcSEcCtD
Azelastine—Abnormal vision—Temozolomide—brain cancer	0.000634	0.00856	CcSEcCtD
Azelastine—Mental disability—Temozolomide—brain cancer	0.000631	0.00851	CcSEcCtD
Azelastine—Ulcer—Etoposide—brain cancer	0.000615	0.0083	CcSEcCtD
Azelastine—Body temperature increased—Carboplatin—brain cancer	0.00061	0.00824	CcSEcCtD
Azelastine—Eye pain—Carmustine—brain cancer	0.000605	0.00816	CcSEcCtD
Azelastine—Gastroenteritis—Temozolomide—brain cancer	0.000595	0.00803	CcSEcCtD
Azelastine—Eye pain—Temozolomide—brain cancer	0.000584	0.00789	CcSEcCtD
Azelastine—HRH3—brain—brain cancer	0.000573	0.024	CbGeAlD
Azelastine—Flushing—Procarbazine—brain cancer	0.00056	0.00756	CcSEcCtD
Azelastine—Body temperature increased—Lomustine—brain cancer	0.000534	0.00721	CcSEcCtD
Azelastine—Weight increased—Hydroxyurea—brain cancer	0.000531	0.00717	CcSEcCtD
Azelastine—Face oedema—Carmustine—brain cancer	0.000527	0.00711	CcSEcCtD
Azelastine—Mouth ulceration—Etoposide—brain cancer	0.000526	0.0071	CcSEcCtD
Azelastine—Tension—Procarbazine—brain cancer	0.000516	0.00696	CcSEcCtD
Azelastine—Nervousness—Procarbazine—brain cancer	0.00051	0.00689	CcSEcCtD
Azelastine—Face oedema—Temozolomide—brain cancer	0.000509	0.00687	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000465	0.00628	CcSEcCtD
Azelastine—Cough—Procarbazine—brain cancer	0.000459	0.00619	CcSEcCtD
Azelastine—Hypertension—Procarbazine—brain cancer	0.000454	0.00612	CcSEcCtD
Azelastine—Myalgia—Procarbazine—brain cancer	0.000447	0.00604	CcSEcCtD
Azelastine—Anxiety—Procarbazine—brain cancer	0.000446	0.00602	CcSEcCtD
Azelastine—CYP2D6—hindbrain—brain cancer	0.00044	0.0184	CbGeAlD
Azelastine—Bronchitis—Temozolomide—brain cancer	0.000439	0.00592	CcSEcCtD
Azelastine—Dry mouth—Procarbazine—brain cancer	0.000438	0.00591	CcSEcCtD
Azelastine—Anaphylactoid reaction—Etoposide—brain cancer	0.000436	0.00589	CcSEcCtD
Azelastine—Confusional state—Procarbazine—brain cancer	0.000433	0.00584	CcSEcCtD
Azelastine—Vomiting—Lomustine—brain cancer	0.00043	0.0058	CcSEcCtD
Azelastine—Infection—Procarbazine—brain cancer	0.000426	0.00575	CcSEcCtD
Azelastine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000424	0.00572	CcSEcCtD
Azelastine—Pollakiuria—Temozolomide—brain cancer	0.000421	0.00569	CcSEcCtD
Azelastine—ADRA1B—head—brain cancer	0.000421	0.0176	CbGeAlD
Azelastine—Tachycardia—Procarbazine—brain cancer	0.000419	0.00565	CcSEcCtD
Azelastine—Weight increased—Temozolomide—brain cancer	0.000415	0.0056	CcSEcCtD
Azelastine—Nausea—Lomustine—brain cancer	0.000401	0.00542	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000391	0.00527	CcSEcCtD
Azelastine—Paraesthesia—Procarbazine—brain cancer	0.000385	0.0052	CcSEcCtD
Azelastine—ADRA1B—central nervous system—brain cancer	0.000384	0.0161	CbGeAlD
Azelastine—Sinusitis—Temozolomide—brain cancer	0.000381	0.00515	CcSEcCtD
Azelastine—Somnolence—Procarbazine—brain cancer	0.000381	0.00515	CcSEcCtD
Azelastine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000377	0.00509	CcSEcCtD
Azelastine—Hypoaesthesia—Carmustine—brain cancer	0.000376	0.00507	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000372	0.00503	CcSEcCtD
Azelastine—Fatigue—Procarbazine—brain cancer	0.00037	0.00499	CcSEcCtD
Azelastine—Malaise—Hydroxyurea—brain cancer	0.000367	0.00495	CcSEcCtD
Azelastine—Pain—Procarbazine—brain cancer	0.000367	0.00495	CcSEcCtD
Azelastine—Constipation—Procarbazine—brain cancer	0.000367	0.00495	CcSEcCtD
Azelastine—KCNH2—telencephalon—brain cancer	0.000367	0.0154	CbGeAlD
Azelastine—Visual impairment—Carmustine—brain cancer	0.000364	0.00491	CcSEcCtD
Azelastine—Hypoaesthesia—Temozolomide—brain cancer	0.000363	0.0049	CcSEcCtD
Azelastine—Pharyngitis—Temozolomide—brain cancer	0.000362	0.00489	CcSEcCtD
Azelastine—Bronchospasm—Etoposide—brain cancer	0.000359	0.00484	CcSEcCtD
Azelastine—Feeling abnormal—Procarbazine—brain cancer	0.000353	0.00477	CcSEcCtD
Azelastine—Eye disorder—Carmustine—brain cancer	0.000353	0.00476	CcSEcCtD
Azelastine—Visual impairment—Temozolomide—brain cancer	0.000352	0.00475	CcSEcCtD
Azelastine—Gastrointestinal pain—Procarbazine—brain cancer	0.000351	0.00473	CcSEcCtD
Azelastine—Flushing—Carmustine—brain cancer	0.000351	0.00473	CcSEcCtD
Azelastine—Discomfort—Hydroxyurea—brain cancer	0.000342	0.00462	CcSEcCtD
Azelastine—Clozapine—CYP2C9—brain cancer	0.000342	0.129	CrCbGaD
Azelastine—Eye disorder—Temozolomide—brain cancer	0.000341	0.0046	CcSEcCtD
Azelastine—Body temperature increased—Procarbazine—brain cancer	0.000339	0.00458	CcSEcCtD
Azelastine—Abdominal pain—Procarbazine—brain cancer	0.000339	0.00458	CcSEcCtD
Azelastine—Flushing—Temozolomide—brain cancer	0.000339	0.00457	CcSEcCtD
Azelastine—CYP2A6—cerebellum—brain cancer	0.000332	0.0139	CbGeAlD
Azelastine—ABCB1—blood vessel—brain cancer	0.000332	0.0139	CbGeAlD
Azelastine—Infection—Hydroxyurea—brain cancer	0.00033	0.00445	CcSEcCtD
Azelastine—Back pain—Carmustine—brain cancer	0.000318	0.00429	CcSEcCtD
Azelastine—Hypersensitivity—Procarbazine—brain cancer	0.000316	0.00426	CcSEcCtD
Azelastine—Dysgeusia—Temozolomide—brain cancer	0.000311	0.0042	CcSEcCtD
Azelastine—Vision blurred—Carmustine—brain cancer	0.00031	0.00418	CcSEcCtD
Azelastine—Asthenia—Procarbazine—brain cancer	0.000308	0.00415	CcSEcCtD
Azelastine—Back pain—Temozolomide—brain cancer	0.000307	0.00415	CcSEcCtD
Azelastine—ADRA1B—brain—brain cancer	0.000305	0.0128	CbGeAlD
Azelastine—Pruritus—Procarbazine—brain cancer	0.000303	0.0041	CcSEcCtD
Azelastine—Agitation—Carmustine—brain cancer	0.000302	0.00408	CcSEcCtD
Azelastine—Vision blurred—Temozolomide—brain cancer	0.000299	0.00404	CcSEcCtD
Azelastine—KCNH2—pituitary gland—brain cancer	0.000299	0.0125	CbGeAlD
Azelastine—Dyspnoea—Hydroxyurea—brain cancer	0.000296	0.00399	CcSEcCtD
Azelastine—Somnolence—Hydroxyurea—brain cancer	0.000295	0.00398	CcSEcCtD
Azelastine—Ill-defined disorder—Temozolomide—brain cancer	0.000295	0.00398	CcSEcCtD
Azelastine—HRH1—telencephalon—brain cancer	0.000294	0.0123	CbGeAlD
Azelastine—Diarrhoea—Procarbazine—brain cancer	0.000293	0.00396	CcSEcCtD
Azelastine—Agitation—Temozolomide—brain cancer	0.000292	0.00394	CcSEcCtD
Azelastine—Hypoaesthesia—Etoposide—brain cancer	0.000291	0.00392	CcSEcCtD
Azelastine—KCNH2—medulla oblongata—brain cancer	0.000288	0.0121	CbGeAlD
Azelastine—Malaise—Temozolomide—brain cancer	0.000287	0.00387	CcSEcCtD
Azelastine—Fatigue—Hydroxyurea—brain cancer	0.000286	0.00386	CcSEcCtD
Azelastine—Vertigo—Temozolomide—brain cancer	0.000285	0.00385	CcSEcCtD
Azelastine—Hypertension—Carmustine—brain cancer	0.000284	0.00383	CcSEcCtD
Azelastine—Constipation—Hydroxyurea—brain cancer	0.000284	0.00383	CcSEcCtD
Azelastine—Pain—Hydroxyurea—brain cancer	0.000284	0.00383	CcSEcCtD
Azelastine—Dizziness—Procarbazine—brain cancer	0.000284	0.00383	CcSEcCtD
Azelastine—CYP2E1—telencephalon—brain cancer	0.000282	0.0118	CbGeAlD
Azelastine—Palpitations—Temozolomide—brain cancer	0.000281	0.00379	CcSEcCtD
Azelastine—Chest pain—Carmustine—brain cancer	0.00028	0.00378	CcSEcCtD
Azelastine—Myalgia—Carmustine—brain cancer	0.00028	0.00378	CcSEcCtD
Azelastine—Anxiety—Carmustine—brain cancer	0.000279	0.00376	CcSEcCtD
Azelastine—Cough—Temozolomide—brain cancer	0.000277	0.00374	CcSEcCtD
Azelastine—Hypertension—Temozolomide—brain cancer	0.000274	0.0037	CcSEcCtD
Azelastine—Feeling abnormal—Hydroxyurea—brain cancer	0.000274	0.00369	CcSEcCtD
Azelastine—CYP2C8—pituitary gland—brain cancer	0.000273	0.0115	CbGeAlD
Azelastine—Eye disorder—Etoposide—brain cancer	0.000273	0.00368	CcSEcCtD
Azelastine—Vomiting—Procarbazine—brain cancer	0.000273	0.00368	CcSEcCtD
Azelastine—Flushing—Etoposide—brain cancer	0.000271	0.00366	CcSEcCtD
Azelastine—Confusional state—Carmustine—brain cancer	0.000271	0.00365	CcSEcCtD
Azelastine—Myalgia—Temozolomide—brain cancer	0.000271	0.00365	CcSEcCtD
Azelastine—Rash—Procarbazine—brain cancer	0.00027	0.00365	CcSEcCtD
Azelastine—Dermatitis—Procarbazine—brain cancer	0.00027	0.00365	CcSEcCtD
Azelastine—CYP2A6—brain—brain cancer	0.00027	0.0113	CbGeAlD
Azelastine—Anxiety—Temozolomide—brain cancer	0.00027	0.00364	CcSEcCtD
Azelastine—Headache—Procarbazine—brain cancer	0.000269	0.00363	CcSEcCtD
Azelastine—Discomfort—Temozolomide—brain cancer	0.000267	0.00361	CcSEcCtD
Azelastine—Infection—Carmustine—brain cancer	0.000267	0.0036	CcSEcCtD
Azelastine—Dry mouth—Temozolomide—brain cancer	0.000265	0.00357	CcSEcCtD
Azelastine—KCNH2—midbrain—brain cancer	0.000263	0.011	CbGeAlD
Azelastine—Body temperature increased—Hydroxyurea—brain cancer	0.000262	0.00354	CcSEcCtD
Azelastine—Tachycardia—Carmustine—brain cancer	0.000262	0.00353	CcSEcCtD
Azelastine—Confusional state—Temozolomide—brain cancer	0.000261	0.00353	CcSEcCtD
Azelastine—Anaphylactic shock—Temozolomide—brain cancer	0.000259	0.0035	CcSEcCtD
Azelastine—Infection—Temozolomide—brain cancer	0.000258	0.00348	CcSEcCtD
Azelastine—KCNH2—spinal cord—brain cancer	0.000257	0.0108	CbGeAlD
Azelastine—Nausea—Procarbazine—brain cancer	0.000255	0.00344	CcSEcCtD
Azelastine—CYP2D6—brainstem—brain cancer	0.000252	0.0106	CbGeAlD
Azelastine—CYP2B6—gonad—brain cancer	0.000251	0.0105	CbGeAlD
Azelastine—Dysgeusia—Etoposide—brain cancer	0.000249	0.00336	CcSEcCtD
Azelastine—Back pain—Etoposide—brain cancer	0.000246	0.00332	CcSEcCtD
Azelastine—Hypersensitivity—Hydroxyurea—brain cancer	0.000245	0.0033	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000245	0.0033	CcSEcCtD
Azelastine—CYP2C19—endocrine gland—brain cancer	0.000242	0.0102	CbGeAlD
Azelastine—Paraesthesia—Carmustine—brain cancer	0.000241	0.00325	CcSEcCtD
Azelastine—Dyspnoea—Carmustine—brain cancer	0.000239	0.00323	CcSEcCtD
Azelastine—Somnolence—Carmustine—brain cancer	0.000239	0.00322	CcSEcCtD
Azelastine—Asthenia—Hydroxyurea—brain cancer	0.000238	0.00321	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000236	0.00319	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—brain cancer	0.000236	0.00318	CcSEcCtD
Azelastine—Paraesthesia—Temozolomide—brain cancer	0.000233	0.00314	CcSEcCtD
Azelastine—KCNH2—endocrine gland—brain cancer	0.000231	0.0097	CbGeAlD
Azelastine—Dyspnoea—Temozolomide—brain cancer	0.000231	0.00312	CcSEcCtD
Azelastine—Somnolence—Temozolomide—brain cancer	0.000231	0.00311	CcSEcCtD
Azelastine—Pain—Carmustine—brain cancer	0.000229	0.0031	CcSEcCtD
Azelastine—Constipation—Carmustine—brain cancer	0.000229	0.0031	CcSEcCtD
Azelastine—Malaise—Etoposide—brain cancer	0.000229	0.00309	CcSEcCtD
Azelastine—Vertigo—Etoposide—brain cancer	0.000228	0.00308	CcSEcCtD
Azelastine—KCNH2—head—brain cancer	0.000228	0.00958	CbGeAlD
Azelastine—Diarrhoea—Hydroxyurea—brain cancer	0.000227	0.00307	CcSEcCtD
Azelastine—CYP2D6—telencephalon—brain cancer	0.000224	0.00938	CbGeAlD
Azelastine—Fatigue—Temozolomide—brain cancer	0.000224	0.00302	CcSEcCtD
Azelastine—CYP2E1—medulla oblongata—brain cancer	0.000222	0.00931	CbGeAlD
Azelastine—Cough—Etoposide—brain cancer	0.000222	0.00299	CcSEcCtD
Azelastine—Constipation—Temozolomide—brain cancer	0.000222	0.00299	CcSEcCtD
Azelastine—Pain—Temozolomide—brain cancer	0.000222	0.00299	CcSEcCtD
Azelastine—Feeling abnormal—Carmustine—brain cancer	0.000221	0.00298	CcSEcCtD
Azelastine—Hypertension—Etoposide—brain cancer	0.00022	0.00296	CcSEcCtD
Azelastine—Dizziness—Hydroxyurea—brain cancer	0.00022	0.00296	CcSEcCtD
Azelastine—Gastrointestinal pain—Carmustine—brain cancer	0.000219	0.00296	CcSEcCtD
Azelastine—Chest pain—Etoposide—brain cancer	0.000216	0.00292	CcSEcCtD
Azelastine—Discomfort—Etoposide—brain cancer	0.000214	0.00289	CcSEcCtD
Azelastine—Feeling abnormal—Temozolomide—brain cancer	0.000214	0.00288	CcSEcCtD
Azelastine—Body temperature increased—Carmustine—brain cancer	0.000212	0.00286	CcSEcCtD
Azelastine—Abdominal pain—Carmustine—brain cancer	0.000212	0.00286	CcSEcCtD
Azelastine—Gastrointestinal pain—Temozolomide—brain cancer	0.000212	0.00286	CcSEcCtD
Azelastine—CYP2C8—endocrine gland—brain cancer	0.000212	0.00888	CbGeAlD
Azelastine—Vomiting—Hydroxyurea—brain cancer	0.000211	0.00285	CcSEcCtD
Azelastine—Rash—Hydroxyurea—brain cancer	0.000209	0.00282	CcSEcCtD
Azelastine—Confusional state—Etoposide—brain cancer	0.000209	0.00282	CcSEcCtD
Azelastine—Dermatitis—Hydroxyurea—brain cancer	0.000209	0.00282	CcSEcCtD
Azelastine—KCNH2—central nervous system—brain cancer	0.000208	0.00874	CbGeAlD
Azelastine—Headache—Hydroxyurea—brain cancer	0.000208	0.00281	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—brain cancer	0.000208	0.0028	CcSEcCtD
Azelastine—Infection—Etoposide—brain cancer	0.000206	0.00278	CcSEcCtD
Azelastine—Body temperature increased—Temozolomide—brain cancer	0.000205	0.00277	CcSEcCtD
Azelastine—Abdominal pain—Temozolomide—brain cancer	0.000205	0.00277	CcSEcCtD
Azelastine—KCNH2—cerebellum—brain cancer	0.000204	0.00854	CbGeAlD
Azelastine—Tachycardia—Etoposide—brain cancer	0.000203	0.00273	CcSEcCtD
Azelastine—CYP1A2—endocrine gland—brain cancer	0.000198	0.00831	CbGeAlD
Azelastine—CYP2E1—spinal cord—brain cancer	0.000198	0.0083	CbGeAlD
Azelastine—Hypersensitivity—Carmustine—brain cancer	0.000198	0.00267	CcSEcCtD
Azelastine—Nausea—Hydroxyurea—brain cancer	0.000197	0.00266	CcSEcCtD
Azelastine—CYP1A1—endocrine gland—brain cancer	0.000195	0.00819	CbGeAlD
Azelastine—CYP1A1—head—brain cancer	0.000193	0.00809	CbGeAlD
Azelastine—Asthenia—Carmustine—brain cancer	0.000193	0.0026	CcSEcCtD
Azelastine—Hypersensitivity—Temozolomide—brain cancer	0.000191	0.00258	CcSEcCtD
Azelastine—CYP3A5—endocrine gland—brain cancer	0.000191	0.00801	CbGeAlD
Azelastine—CYP2B6—endocrine gland—brain cancer	0.00019	0.00796	CbGeAlD
Azelastine—CYP2C9—endocrine gland—brain cancer	0.000188	0.00788	CbGeAlD
Azelastine—CYP2B6—head—brain cancer	0.000187	0.00786	CbGeAlD
Azelastine—Paraesthesia—Etoposide—brain cancer	0.000186	0.00251	CcSEcCtD
Azelastine—Asthenia—Temozolomide—brain cancer	0.000186	0.00251	CcSEcCtD
Azelastine—HRH1—endocrine gland—brain cancer	0.000185	0.00778	CbGeAlD
Azelastine—Dyspnoea—Etoposide—brain cancer	0.000185	0.0025	CcSEcCtD
Azelastine—Somnolence—Etoposide—brain cancer	0.000184	0.00249	CcSEcCtD
Azelastine—Diarrhoea—Carmustine—brain cancer	0.000184	0.00248	CcSEcCtD
Azelastine—Pruritus—Temozolomide—brain cancer	0.000183	0.00248	CcSEcCtD
Azelastine—HRH1—head—brain cancer	0.000183	0.00768	CbGeAlD
Azelastine—Fatigue—Etoposide—brain cancer	0.000179	0.00241	CcSEcCtD
Azelastine—CYP2E1—endocrine gland—brain cancer	0.000178	0.00747	CbGeAlD
Azelastine—Dizziness—Carmustine—brain cancer	0.000177	0.00239	CcSEcCtD
Azelastine—Constipation—Etoposide—brain cancer	0.000177	0.00239	CcSEcCtD
Azelastine—Pain—Etoposide—brain cancer	0.000177	0.00239	CcSEcCtD
Azelastine—Diarrhoea—Temozolomide—brain cancer	0.000177	0.00239	CcSEcCtD
Azelastine—CYP1A1—central nervous system—brain cancer	0.000176	0.00738	CbGeAlD
Azelastine—CYP2E1—head—brain cancer	0.000176	0.00738	CbGeAlD
Azelastine—Dizziness—Temozolomide—brain cancer	0.000171	0.00231	CcSEcCtD
Azelastine—CYP2B6—central nervous system—brain cancer	0.000171	0.00717	CbGeAlD
Azelastine—Feeling abnormal—Etoposide—brain cancer	0.000171	0.00231	CcSEcCtD
Azelastine—Vomiting—Carmustine—brain cancer	0.000171	0.0023	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—brain cancer	0.00017	0.00229	CcSEcCtD
Azelastine—Rash—Carmustine—brain cancer	0.000169	0.00228	CcSEcCtD
Azelastine—Dermatitis—Carmustine—brain cancer	0.000169	0.00228	CcSEcCtD
Azelastine—Headache—Carmustine—brain cancer	0.000168	0.00227	CcSEcCtD
Azelastine—HRH1—central nervous system—brain cancer	0.000167	0.00701	CbGeAlD
Azelastine—KCNH2—brain—brain cancer	0.000165	0.00694	CbGeAlD
Azelastine—Vomiting—Temozolomide—brain cancer	0.000165	0.00223	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—brain cancer	0.000164	0.00221	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—brain cancer	0.000164	0.00221	CcSEcCtD
Azelastine—Rash—Temozolomide—brain cancer	0.000164	0.00221	CcSEcCtD
Azelastine—Dermatitis—Temozolomide—brain cancer	0.000163	0.0022	CcSEcCtD
Azelastine—Headache—Temozolomide—brain cancer	0.000162	0.00219	CcSEcCtD
Azelastine—ABCB1—telencephalon—brain cancer	0.000161	0.00675	CbGeAlD
Azelastine—CYP2E1—central nervous system—brain cancer	0.000161	0.00673	CbGeAlD
Azelastine—Nausea—Carmustine—brain cancer	0.000159	0.00215	CcSEcCtD
Azelastine—CYP2E1—cerebellum—brain cancer	0.000157	0.00658	CbGeAlD
Azelastine—Nausea—Temozolomide—brain cancer	0.000154	0.00208	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—brain cancer	0.000153	0.00206	CcSEcCtD
Azelastine—CYP2C8—brain—brain cancer	0.000151	0.00635	CbGeAlD
Azelastine—Asthenia—Etoposide—brain cancer	0.000149	0.00201	CcSEcCtD
Azelastine—Pruritus—Etoposide—brain cancer	0.000147	0.00198	CcSEcCtD
Azelastine—CYP3A4—endocrine gland—brain cancer	0.000143	0.00601	CbGeAlD
Azelastine—Diarrhoea—Etoposide—brain cancer	0.000142	0.00192	CcSEcCtD
Azelastine—CYP2D6—endocrine gland—brain cancer	0.000141	0.00592	CbGeAlD
Azelastine—CYP1A1—brain—brain cancer	0.00014	0.00586	CbGeAlD
Azelastine—CYP2D6—head—brain cancer	0.000139	0.00584	CbGeAlD
Azelastine—Dizziness—Etoposide—brain cancer	0.000137	0.00185	CcSEcCtD
Azelastine—CYP2B6—brain—brain cancer	0.000136	0.0057	CbGeAlD
Azelastine—ABCB1—gonad—brain cancer	0.000134	0.00563	CbGeAlD
Azelastine—HRH1—brain—brain cancer	0.000133	0.00556	CbGeAlD
Azelastine—Vomiting—Etoposide—brain cancer	0.000132	0.00178	CcSEcCtD
Azelastine—ABCB1—pituitary gland—brain cancer	0.000131	0.00549	CbGeAlD
Azelastine—Rash—Etoposide—brain cancer	0.000131	0.00177	CcSEcCtD
Azelastine—Dermatitis—Etoposide—brain cancer	0.000131	0.00176	CcSEcCtD
Azelastine—Headache—Etoposide—brain cancer	0.00013	0.00175	CcSEcCtD
Azelastine—CYP3A4—central nervous system—brain cancer	0.000129	0.00542	CbGeAlD
Azelastine—CYP2E1—brain—brain cancer	0.000127	0.00535	CbGeAlD
Azelastine—CYP2D6—central nervous system—brain cancer	0.000127	0.00533	CbGeAlD
Azelastine—ABCB1—medulla oblongata—brain cancer	0.000126	0.0053	CbGeAlD
Azelastine—CYP2D6—cerebellum—brain cancer	0.000124	0.00521	CbGeAlD
Azelastine—Nausea—Etoposide—brain cancer	0.000123	0.00166	CcSEcCtD
Azelastine—ABCB1—midbrain—brain cancer	0.000116	0.00484	CbGeAlD
Azelastine—ABCB1—spinal cord—brain cancer	0.000113	0.00473	CbGeAlD
Azelastine—ABCB1—endocrine gland—brain cancer	0.000101	0.00426	CbGeAlD
Azelastine—CYP2D6—brain—brain cancer	0.000101	0.00423	CbGeAlD
Azelastine—ABCB1—head—brain cancer	0.0001	0.0042	CbGeAlD
Azelastine—ABCB1—central nervous system—brain cancer	9.14e-05	0.00383	CbGeAlD
Azelastine—ABCB1—cerebellum—brain cancer	8.94e-05	0.00375	CbGeAlD
Azelastine—ABCB1—brain—brain cancer	7.26e-05	0.00304	CbGeAlD
Azelastine—ADRA1B—LPA receptor mediated events—EGFR—brain cancer	6.31e-05	0.000922	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—GLI1—brain cancer	6.28e-05	0.000917	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—VAV1—brain cancer	6.11e-05	0.000893	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	6.08e-05	0.000888	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	6e-05	0.000877	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SUFU—brain cancer	5.95e-05	0.00087	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.87e-05	0.000858	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.87e-05	0.000858	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.76e-05	0.000842	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.75e-05	0.00084	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—GFAP—brain cancer	5.74e-05	0.000839	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—VAV1—brain cancer	5.55e-05	0.000811	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.5e-05	0.000804	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—SHH—brain cancer	5.46e-05	0.000798	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HEY1—brain cancer	5.44e-05	0.000795	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PTCH2—brain cancer	5.44e-05	0.000795	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.43e-05	0.000794	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—DLL1—brain cancer	5.34e-05	0.00078	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—PTCH1—brain cancer	5.18e-05	0.000757	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—SMO—brain cancer	5.18e-05	0.000757	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.04e-05	0.000737	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	5.04e-05	0.000736	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—OR4C12—brain cancer	4.99e-05	0.000729	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—OR14C36—brain cancer	4.99e-05	0.000729	CbGpPWpGaD
Azelastine—ADRA1B—AMPK Signaling—TP53—brain cancer	4.98e-05	0.000729	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—SHH—brain cancer	4.94e-05	0.000723	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PTCH2—brain cancer	4.93e-05	0.00072	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.89e-05	0.000715	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.86e-05	0.000711	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—ABR—brain cancer	4.7e-05	0.000687	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—SMO—brain cancer	4.69e-05	0.000685	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—PTCH1—brain cancer	4.69e-05	0.000685	CbGpPWpGaD
Azelastine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.56e-05	0.000666	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SHH—brain cancer	4.54e-05	0.000663	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—OR14C36—brain cancer	4.52e-05	0.00066	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—OR4C12—brain cancer	4.52e-05	0.00066	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.5e-05	0.000658	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TRPC6—brain cancer	4.38e-05	0.00064	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PTCH1—brain cancer	4.3e-05	0.000629	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SMO—brain cancer	4.3e-05	0.000629	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—ABR—brain cancer	4.27e-05	0.000624	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—ABR—brain cancer	4.26e-05	0.000622	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DTX2—brain cancer	4.24e-05	0.00062	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.16e-05	0.000608	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.02e-05	0.000588	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.99e-05	0.000584	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—IL2—brain cancer	3.98e-05	0.000581	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.92e-05	0.000572	CbGpPWpGaD
Azelastine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.9e-05	0.00057	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—PIK3CG—brain cancer	3.88e-05	0.000567	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.87e-05	0.000565	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—ABR—brain cancer	3.87e-05	0.000565	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DTX2—brain cancer	3.84e-05	0.000561	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.82e-05	0.000559	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.74e-05	0.000547	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.74e-05	0.000547	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.68e-05	0.000539	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.6e-05	0.000526	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—PIK3CG—brain cancer	3.52e-05	0.000515	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.51e-05	0.000512	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NOTCH2—brain cancer	3.44e-05	0.000503	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.43e-05	0.000501	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.38e-05	0.000494	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.29e-05	0.000481	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP2C9—brain cancer	3.29e-05	0.00048	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VAV1—brain cancer	3.28e-05	0.000479	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTCH2—brain cancer	3.21e-05	0.00047	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HES5—brain cancer	3.11e-05	0.000455	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STRADA—brain cancer	3.02e-05	0.000442	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3e-05	0.000438	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—TRPC6—brain cancer	2.98e-05	0.000435	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.96e-05	0.000433	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTCH2—brain cancer	2.91e-05	0.000425	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HES1—brain cancer	2.82e-05	0.000412	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HES5—brain cancer	2.82e-05	0.000412	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—SHH—brain cancer	2.8e-05	0.00041	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—BSG—brain cancer	2.79e-05	0.000408	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.79e-05	0.000408	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STRADA—brain cancer	2.74e-05	0.0004	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—IL2—brain cancer	2.73e-05	0.000399	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—TRPC6—brain cancer	2.7e-05	0.000395	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	2.69e-05	0.000394	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PDGFRA—brain cancer	2.68e-05	0.000392	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PTCH1—brain cancer	2.66e-05	0.000388	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—SMO—brain cancer	2.66e-05	0.000388	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.65e-05	0.000388	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SPP1—brain cancer	2.61e-05	0.000381	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.6e-05	0.00038	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP2C9—brain cancer	2.59e-05	0.000379	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.56e-05	0.000375	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—SHH—brain cancer	2.54e-05	0.000371	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ABR—brain cancer	2.52e-05	0.000369	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL2—brain cancer	2.48e-05	0.000362	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP2C9—brain cancer	2.45e-05	0.000358	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—TRPC6—brain cancer	2.45e-05	0.000358	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GLI2—brain cancer	2.44e-05	0.000356	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—SMO—brain cancer	2.41e-05	0.000352	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PTCH1—brain cancer	2.41e-05	0.000352	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—IDH1—brain cancer	2.4e-05	0.000351	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.39e-05	0.00035	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IRS2—brain cancer	2.36e-05	0.000345	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.33e-05	0.00034	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GLI1—brain cancer	2.29e-05	0.000335	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ABR—brain cancer	2.28e-05	0.000334	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—BSG—brain cancer	2.25e-05	0.00033	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.24e-05	0.000328	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—VAV1—brain cancer	2.23e-05	0.000326	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—BSG—brain cancer	2.21e-05	0.000323	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GLI2—brain cancer	2.21e-05	0.000322	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—BSG—brain cancer	2.2e-05	0.000322	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SUFU—brain cancer	2.17e-05	0.000317	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.16e-05	0.000316	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.16e-05	0.000316	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GFAP—brain cancer	2.09e-05	0.000306	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—BSG—brain cancer	2.08e-05	0.000304	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—APC—brain cancer	2.08e-05	0.000304	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PIK3CG—brain cancer	2.08e-05	0.000304	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GLI1—brain cancer	2.07e-05	0.000303	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—VAV1—brain cancer	2.03e-05	0.000296	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—VAV1—brain cancer	2.02e-05	0.000295	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP2C9—brain cancer	2e-05	0.000293	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HEY1—brain cancer	1.99e-05	0.00029	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SUFU—brain cancer	1.97e-05	0.000287	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP2C9—brain cancer	1.96e-05	0.000286	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—DLL1—brain cancer	1.95e-05	0.000285	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—IDH1—brain cancer	1.94e-05	0.000283	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.91e-05	0.00028	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—BSG—brain cancer	1.91e-05	0.000279	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ENO2—brain cancer	1.9e-05	0.000278	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—IDH1—brain cancer	1.9e-05	0.000278	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—EGFR—brain cancer	1.9e-05	0.000277	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GFAP—brain cancer	1.9e-05	0.000277	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—IDH1—brain cancer	1.89e-05	0.000277	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.89e-05	0.000277	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000269	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—VAV1—brain cancer	1.83e-05	0.000268	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HEY1—brain cancer	1.8e-05	0.000263	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—IDH1—brain cancer	1.79e-05	0.000262	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—DLL1—brain cancer	1.76e-05	0.000258	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—BSG—brain cancer	1.7e-05	0.000249	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.67e-05	0.000244	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—BSG—brain cancer	1.66e-05	0.000243	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SHH—brain cancer	1.66e-05	0.000242	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—IDH1—brain cancer	1.64e-05	0.00024	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—RELA—brain cancer	1.63e-05	0.000238	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—ERBB2—brain cancer	1.62e-05	0.000236	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TRPC6—brain cancer	1.6e-05	0.000233	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SMO—brain cancer	1.57e-05	0.000229	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTCH1—brain cancer	1.57e-05	0.000229	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—BSG—brain cancer	1.57e-05	0.000229	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.56e-05	0.000228	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—BSG—brain cancer	1.55e-05	0.000227	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.53e-05	0.000224	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ENO2—brain cancer	1.53e-05	0.000224	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ENO2—brain cancer	1.5e-05	0.000219	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.5e-05	0.000219	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SHH—brain cancer	1.5e-05	0.000219	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ENO2—brain cancer	1.5e-05	0.000219	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—IDH1—brain cancer	1.46e-05	0.000214	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL2—brain cancer	1.46e-05	0.000214	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.46e-05	0.000213	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TRPC6—brain cancer	1.45e-05	0.000211	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—IDH1—brain cancer	1.43e-05	0.000209	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCND1—brain cancer	1.43e-05	0.000209	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SMO—brain cancer	1.42e-05	0.000208	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTCH1—brain cancer	1.42e-05	0.000208	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	1.42e-05	0.000207	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ENO2—brain cancer	1.41e-05	0.000207	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CTNNB1—brain cancer	1.41e-05	0.000207	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—IDH1—brain cancer	1.35e-05	0.000197	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.34e-05	0.000195	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—IDH1—brain cancer	1.34e-05	0.000195	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—BSG—brain cancer	1.33e-05	0.000194	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ENO2—brain cancer	1.3e-05	0.00019	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	1.29e-05	0.000188	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.28e-05	0.000187	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.26e-05	0.000184	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	1.25e-05	0.000183	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VEGFA—brain cancer	1.24e-05	0.000182	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—STAT3—brain cancer	1.23e-05	0.00018	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.2e-05	0.000176	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VAV1—brain cancer	1.2e-05	0.000175	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.19e-05	0.000174	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.16e-05	0.00017	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ENO2—brain cancer	1.16e-05	0.000169	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MYC—brain cancer	1.15e-05	0.000167	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—IDH1—brain cancer	1.14e-05	0.000167	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.14e-05	0.000166	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ENO2—brain cancer	1.13e-05	0.000165	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EGFR—brain cancer	1.12e-05	0.000164	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.09e-05	0.000159	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VAV1—brain cancer	1.08e-05	0.000158	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ENO2—brain cancer	1.07e-05	0.000156	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ENO2—brain cancer	1.06e-05	0.000154	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HES1—brain cancer	1.03e-05	0.00015	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—BSG—brain cancer	1.02e-05	0.00015	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	9.96e-06	0.000146	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	9.8e-06	0.000143	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SPP1—brain cancer	9.51e-06	0.000139	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—brain cancer	9.41e-06	0.000137	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HES1—brain cancer	9.31e-06	0.000136	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.29e-06	0.000136	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL2—brain cancer	9.05e-06	0.000132	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ENO2—brain cancer	9.02e-06	0.000132	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—IL2—brain cancer	9.02e-06	0.000132	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PDGFRA—brain cancer	8.87e-06	0.00013	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—IDH1—brain cancer	8.81e-06	0.000129	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CG—brain cancer	8.71e-06	0.000127	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SPP1—brain cancer	8.61e-06	0.000126	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IRS2—brain cancer	8.6e-06	0.000126	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL2—brain cancer	8.19e-06	0.00012	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IRS2—brain cancer	7.79e-06	0.000114	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	7.6e-06	0.000111	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APC—brain cancer	7.6e-06	0.000111	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CG—brain cancer	7.03e-06	0.000103	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ENO2—brain cancer	6.96e-06	0.000102	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	6.92e-06	0.000101	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CG—brain cancer	6.88e-06	0.000101	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CG—brain cancer	6.88e-06	0.000101	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APC—brain cancer	6.88e-06	0.000101	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CG—brain cancer	6.87e-06	0.0001	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CG—brain cancer	6.49e-06	9.49e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—brain cancer	6.26e-06	9.16e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.95e-06	8.7e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RELA—brain cancer	5.94e-06	8.68e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	5.9e-06	8.62e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RELA—brain cancer	5.37e-06	7.85e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—brain cancer	5.35e-06	7.81e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB2—brain cancer	5.34e-06	7.8e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.31e-06	7.76e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCND1—brain cancer	5.21e-06	7.62e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CG—brain cancer	5.18e-06	7.58e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	5.16e-06	7.54e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.89e-06	7.14e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.84e-06	7.08e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—brain cancer	4.84e-06	7.07e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCND1—brain cancer	4.72e-06	6.9e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CTNNB1—brain cancer	4.67e-06	6.83e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	4.54e-06	6.64e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—brain cancer	4.5e-06	6.58e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—brain cancer	4.18e-06	6.11e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.14e-06	6.05e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—brain cancer	4.11e-06	6.01e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—brain cancer	4.09e-06	5.98e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—brain cancer	4.07e-06	5.95e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—brain cancer	3.78e-06	5.53e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—brain cancer	3.7e-06	5.41e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—brain cancer	3.43e-06	5.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.19e-06	4.67e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—brain cancer	3.11e-06	4.54e-05	CbGpPWpGaD
